Literature DB >> 23996732

Does bicarbonate prevent contrast-induced nephropathy in cardiovascular patients undergoing contrast imaging?

Dilan Dabare1, Mohammed Banihani, Paul Gibbs, Perbinder Grewal.   

Abstract

A best evidence topic in cardiovascular surgery was written according to a structured protocol. The question addressed was whether administering sodium bicarbonate (NaHCO3) prevents contrast-induced nephropathy (CIN) in cardiovascular patients undergoing contrast imaging. In total, 266 papers were found using the reported search, 16 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. CIN is thought to occur as a result of ischaemic or oxidative injury to the kidney. It is postulated that NaHCO3attenuates this renal damage by alkanizing renal tubular fluid thus reducing the generation of contrast-induced free radicals, which damage the kidney. Of the 16 trials, 15 recruited patients with various degrees of renal dysfunction at baseline. The benefit of using NaHCO3 was demonstrated at all stages of chronic kidney disease. Apart from four studies, 12 studies used low toxicity, low-osmolar contrast. Merten et al. published the first trial of NaHCO3 vs (saline) NaCl in preventing CIN, demonstrated a significantly lower rate in the NaHCO3 group and advocated its widespread use. Subsequent trials using the same regimen have collaborated these results. However, more recently, Gomes et al. concluded that NaHCO3 is not superior to saline-based hydration. Similarly, Brar et al. randomized 323 patients with moderate-to-severe renal insufficiency to receive either an NaHCO3 or an NaCl infusion and observed no difference in CIN rates. Two studies investigated the effects of rapid urine alkanization with bolus injections of NaHCO3 prior to contrast and found significant reductions in CIN rates compared with NaCl-treated groups. One study observed that NaCl is superior to NaHCO3, while all other studies showed a beneficial effect or no difference between NaCl- and NaHCO3-based hydration. The most recent meta-analysis by Jang et al. incorporated 3609 patients across 19 trials and concluded that NaHCO3-based hydration regimens are superior to NaCl-based ones. Based on this review, the authors recommend NaHCO3 alongside an NaCl hydration regimen. The exact regimen will depend on the context within which contrast is being administered and needs further evaluation.

Entities:  

Keywords:  Bicarbonate; Contrast; Kidney failure; Nephropathy

Mesh:

Substances:

Year:  2013        PMID: 23996732      PMCID: PMC3829505          DOI: 10.1093/icvts/ivt390

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  17 in total

1.  Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.

Authors:  Mauro Maioli; Anna Toso; Mario Leoncini; Carlo Micheletti; Francesco Bellandi
Journal:  Circ Cardiovasc Interv       Date:  2011-10-04       Impact factor: 6.546

2.  Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial.

Authors:  Ali Vasheghani-Farahani; Gelareh Sadigh; Seyed Ebrahim Kassaian; Seyed Mohammad Reza Khatami; Akbar Fotouhi; Seyed Amirhossein Razavi; Mohammad Ali Mansournia; Ali Kazemisaeid; Abbas Soleimani; Hamid Reza Pourhosseini; Mohammad Alidoosti; Ali Mohammad Hajizeinali; Kianoush Hoseini; Ebrahim Nematipour
Journal:  J Nephrol       Date:  2010 Mar-Apr       Impact factor: 3.902

3.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

4.  Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial.

Authors:  Theresia Klima; Andreas Christ; Ivana Marana; Stefan Kalbermatter; Heiko Uthoff; Emanuel Burri; Sabine Hartwiger; Christian Schindler; Tobias Breidthardt; Giancarlo Marenzi; Christian Mueller
Journal:  Eur Heart J       Date:  2012-01-19       Impact factor: 29.983

5.  Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures.

Authors:  Hiromichi Ueda; Takahisa Yamada; Masaharu Masuda; Yuji Okuyama; Takashi Morita; Yoshio Furukawa; Tanaka Koji; Yusuke Iwasaki; Takeshi Okada; Masato Kawasaki; Yuki Kuramoto; Takashi Naito; Tadao Fujimoto; Issei Komuro; Masatake Fukunami
Journal:  Am J Cardiol       Date:  2011-02-23       Impact factor: 2.778

Review 6.  Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury – a systematic review and meta-analysis –.

Authors:  Jae-Sik Jang; Han-Young Jin; Jeong-Sook Seo; Tae-Hyun Yang; Dae-Kyeong Kim; Tae Hee Kim; Sang-Hwa Urm; Dong-Soo Kim; Dong-Kie Kim; Sang-Hoon Seol; Doo-Il Kim; Kyoung-Im Cho; Bo-Hyun Kim; Yong Hyun Park; Hyung-Gon Je; Jung-Min Ahn; Won-Jang Kim; Jong-Young Lee; Seung-Whan Lee
Journal:  Circ J       Date:  2012-06-07       Impact factor: 2.993

7.  Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.

Authors:  Akira Tamura; Yukie Goto; Kumie Miyamoto; Shigeru Naono; Yoshiyuki Kawano; Munenori Kotoku; Toru Watanabe; Junichi Kadota
Journal:  Am J Cardiol       Date:  2009-10-01       Impact factor: 2.778

8.  Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.

Authors:  Somjot S Brar; Albert Yuh-Jer Shen; Michael B Jorgensen; Adam Kotlewski; Vicken J Aharonian; Natasha Desai; Michael Ree; Ahmed Ijaz Shah; Raoul J Burchette
Journal:  JAMA       Date:  2008-09-03       Impact factor: 56.272

9.  Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.

Authors:  Ali Vasheghani-Farahani; Gelareh Sadigh; Seyed Ebrahim Kassaian; Seyed Mohammad Reza Khatami; Akbar Fotouhi; Seyed Amir Hossein Razavi; Mohammad Ali Mansournia; Ahmad Yamini-Sharif; Alireza Amirzadegan; Mojtaba Salarifar; Saeed Sadeghian; Gholamreza Davoodi; Mohammad Ali Borumand; Farah Aiatollahzade Esfehani; Sirous Darabian
Journal:  Am J Kidney Dis       Date:  2009-07-19       Impact factor: 8.860

10.  Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.

Authors:  Vitor O Gomes; Ricardo Lasevitch; Valter C Lima; Fábio S Brito; Juan Carlos Perez-Alva; Bruno Moulin; Airton Arruda; Denise Oliveira; Paulo Caramori
Journal:  Arq Bras Cardiol       Date:  2012-11-27       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.